These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8186951)

  • 41. An autopsy case of early ("minimal change") olivopontocerebellar atrophy (multiple system atrophy-cerebellar).
    Wakabayashi K; Mori F; Nishie M; Oyama Y; Kurihara A; Yoshimoto M; Kuroda N
    Acta Neuropathol; 2005 Aug; 110(2):185-90. PubMed ID: 15971057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Argyrophilic ubiquitinated cytoplasmic inclusions of Leu-7-positive glial cells in olivopontocerebellar atrophy (multiple system atrophy).
    Kato S; Nakamura H; Hirano A; Ito H; Llena JF; Yen SH
    Acta Neuropathol; 1991; 82(6):488-93. PubMed ID: 1723828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple system atrophy.
    Kulczycki J
    Folia Neuropathol; 1997; 35(4):209-13. PubMed ID: 9833397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. alpha-Synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy.
    Gai WP; Pountney DL; Power JH; Li QX; Culvenor JG; McLean CA; Jensen PH; Blumbergs PC
    Exp Neurol; 2003 May; 181(1):68-78. PubMed ID: 12710935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease--a retrospective comparison.
    Magalhães M; Wenning GK; Daniel SE; Quinn NP
    Acta Neurol Scand; 1995 Feb; 91(2):98-102. PubMed ID: 7785431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel grading scale for striatonigral degeneration (multiple system atrophy).
    Wenning GK; Seppi K; Tison F; Jellinger K
    J Neural Transm (Vienna); 2002 Mar; 109(3):307-20. PubMed ID: 11956953
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuropathology of multiple system atrophy: new thoughts about pathogenesis.
    Jellinger KA
    Mov Disord; 2014 Dec; 29(14):1720-41. PubMed ID: 25297524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progressive accumulation of ubiquitin and disappearance of alpha-synuclein epitope in multiple system atrophy-associated glial cytoplasmic inclusions: triple fluorescence study combined with Gallyas-Braak method.
    Sakamoto M; Uchihara T; Nakamura A; Mizutani T; Mizusawa H
    Acta Neuropathol; 2005 Oct; 110(4):417-25. PubMed ID: 16133540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple system atrophy with severe involvement of the motor cortical areas and cerebral white matter.
    Wakabayashi K; Ikeuchi T; Ishikawa A; Takahashi H
    J Neurol Sci; 1998; 156(1):114-7. PubMed ID: 9559999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distribution of neuronal cytoplasmic inclusions in multiple system atrophy.
    Sugiura K; Hashizume Y; Kume A; Takahashi A
    Nagoya J Med Sci; 1995 Dec; 58(3-4):117-26. PubMed ID: 8725495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.
    Tu PH; Galvin JE; Baba M; Giasson B; Tomita T; Leight S; Nakajo S; Iwatsubo T; Trojanowski JQ; Lee VM
    Ann Neurol; 1998 Sep; 44(3):415-22. PubMed ID: 9749615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Olivopontocerebellar atrophy associated with nigrostriatal degeneration].
    Ricart C; Lamarca J; Balaguer E; Fossas P
    Rev Clin Esp; 1986 Nov; 179(8):432-3. PubMed ID: 3470856
    [No Abstract]   [Full Text] [Related]  

  • 53. The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint.
    Kaindlstorfer C; Jellinger KA; Eschlböck S; Stefanova N; Weiss G; Wenning GK
    J Alzheimers Dis; 2018; 61(4):1253-1273. PubMed ID: 29376857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survival of patients with pathologically proven multiple system atrophy: a meta-analysis.
    Ben-Shlomo Y; Wenning GK; Tison F; Quinn NP
    Neurology; 1997 Feb; 48(2):384-93. PubMed ID: 9040727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy.
    Fernagut PO; Meissner WG; Biran M; Fantin M; Bassil F; Franconi JM; Tison F
    Synapse; 2014 Mar; 68(3):98-106. PubMed ID: 24243499
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survival in multiple system atrophy: a study of prognostic factors in 59 cases.
    Testa D; Filippini G; Farinotti M; Palazzini E; Caraceni T
    J Neurol; 1996 May; 243(5):401-4. PubMed ID: 8741080
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunohistochemical quantification of substance P in spinal dorsal horns of patients with multiple system atrophy.
    Tomokane N; Kitamoto T; Tateishi J; Sato Y
    J Neurol Neurosurg Psychiatry; 1991 Jun; 54(6):535-41. PubMed ID: 1715385
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update.
    Jellinger KA; Lantos PL
    Acta Neuropathol; 2010 Jun; 119(6):657-67. PubMed ID: 20309568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebral cortical pathology of sporadic olivopontocerebellar atrophy.
    Fujita T; Doi M; Ogata T; Kanazawa I; Mizusawa H
    J Neurol Sci; 1993 May; 116(1):41-6. PubMed ID: 8251013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunohistochemical study of substance P in the substantia nigra of multiple system atrophy.
    Nomura H; Konno H; Takase S; Saito H
    Regul Pept; 1993 Jul; 46(1-2):247-50. PubMed ID: 7692506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.